The first-of-its-kind study published last week in the the 'American Journal of

ScientiFix, our weekly feature, offers you a summary of the top global science stories of

ScientiFix, our weekly feature, offers you a summary of the top global science stories of

Semaglutide once a week reduced risk of adverse outcomes in kidney patients by 24 percent